Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Migraine in a nurse’s practice

DOI: https://doi.org/10.29296/25879979-2021-06-15
Download full text PDF
Issue: 
6
Year: 
2021

V.V. Skvortsov, G.I. Malyakin, N.D. Matveyev Volgograd state medical university», Russian Health Ministry

Migraine is a common neurological disorder that presents with a moderate to severe throbbing headache, usually one-sided, lasting 4 to 72 hours, accompanied by nausea, vomiting, and intolerance to light (photophobia) and sound (phonophobia). This disease affects 12.6% of the population (6% of men, 18% of women), and according to the WHO, it is one of the 20 most severe diseases in the world. Modifiable risk factors for the development and differential diagnosis of chronic migraine are described. The principles of migraine treatment are presented, taking into account the level of evidence of the main groups of drugs for migraine, their possible side effects and complications [4, 6].
Keywords: 
migraine
migraine attack treatment
triptans
sumatriptan

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. Edinburgh: SIGN; 2018. (SIGN publication no. 155). [February 2018].
  2. Roberta Giroldini, Lucia Magnano, Anna Maria Marata, Francesco Nonino, Elisabetta Pasi, Maria Chiara Silvani, Elisa Baldin, Maria Chiara Bassi. Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion WHO Model List Application, December, 2018
  3. Amelin A.V., Ignatov Ju.D., Skoromets A.A., Sokolov A.Ju. Migren' (patogenez, klinika, lechenie). — M.: MEDpress, 2011. — 265 s.
  4. Esin O.R., Naprienko M.V., Esin R.G. Migren': osnovnye printsipy lechenija i profilaktiki / Klinitsist №4 2011 S. 10-16.
  5. Osipova V.V. Effektivnoe kupirovanie pristupov migreni / Farmateka №13 – 2015 S. 79-83.
  6. Sviridova N.K. Osobennosti diagnostiki i lechenija golovnoj boli, svjazannoj s pristupami migreni / East European journal of neurology 01(01) janvar'-fevral' 2015 S. 8-12.
  7. Sergeev A.V., Tabeeva G.R., Azimova Ju.E. Tsentral'naja nejronal'naja gipervozbudimost' - predispozitsija k migreni. Rossijskij zhurnal boli. 2010;2 (27):3-11.
  8. Studenikin V.M., Pak L.A., Tursunhuzhaeva S.Sh. [i dr.] Migren' i sovremennye podhody k ee lecheniju. / Meditsinskij sovet. – 2010. – №9-10. – S. 80-83.
  9. Tabeeva G.R., Azimova Ju.E. Effektivnost' sumamigrena pri ego naznachenii v rannem i pozdnem periodah razvitija migrenoznogo pristupa / Zhurnal nevrologii i psihiatrii im. S.S. Korsakova – 2007. – T.107. – № 8. – S. 29-34.
  10. Tabeeva G.R. Analiz strategij farmakoterapii pristupov migreni / Spravochnik poliklinicheskogo vracha. – 2014. – № 2. – S. 34-39.
  11. Filatova E.G., Osipova V.V., Tabeeva G.R. [i dr.] Diagnostika i lechenie migreni: rekomendatsii rossijskih ekspertov / Nevrologija, nejropsihiatrija, psihosomatika. 2020. – T. 12. – № 4. – S.4–14.